Why Asthma Research Is Expanding Right Now
Walk into any major allergy and asthma clinic in the United States and you will notice something: the conversation has shifted. Doctors are talking less about managing symptoms indefinitely and more about targeting the underlying mechanisms of the disease. Biologic therapies — medications like benralizumab, tezepelumab, and dupilumab — have reshaped the landscape for people with moderate to severe eosinophilic asthma and allergic asthma. These drugs did not appear overnight. Each one passed through multiple phases of clinical trials, many of which were conducted at research hospitals and private clinics across the country.
The National Heart, Lung, and Blood Institute continues to fund studies that examine everything from technology-based asthma management in children to airway remodeling in adults who have lived with the condition for decades. Pharmaceutical companies, including AstraZeneca, Eli Lilly, and Generate Biomedicines, are actively recruiting participants for trials in cities like Tempe, Arizona; Chicago, Illinois; and multiple sites across the Midwest. The sheer volume of active studies means that patients who once felt stuck now have options worth investigating.
That said, clinical trials are not a quick fix. They are structured, monitored, and bound by protocols that can feel overwhelming at first glance. Understanding how they work — and whether one is right for you — starts with cutting through the noise.
What Kinds of Asthma Trials Are Available
Not all asthma clinical trials look the same. Some test new medications. Others compare existing treatments in new combinations. A growing number focus on non-drug interventions, like digital health tools or breathing retraining programs.
Interventional trials are the most common type. Participants receive a specific treatment — a new inhaler, an injectable biologic, or an oral medication — and researchers track the results over weeks or months. These are often randomized and placebo-controlled, meaning some participants receive the active drug while others receive a placebo. Neither you nor the study team knows which group you are in, a design that helps eliminate bias.
Observational studies take a different approach. Instead of giving participants a treatment, researchers observe people over time to understand how asthma progresses or how certain lifestyle factors influence outcomes. These studies tend to be less demanding but also offer no direct therapeutic benefit.
The phase of the trial matters. Phase I studies focus on safety and involve small groups. Phase II expands to more participants and explores dosing. Phase III trials are large — sometimes spanning dozens of sites across the U.S. — and compare the new treatment against the current standard of care. Phase IV studies happen after a drug is already on the market, gathering long-term safety data.
For someone with severe uncontrolled asthma who has tried high-dose inhaled corticosteroids and long-acting beta-agonists without relief, a Phase II or Phase III biologic trial could be worth discussing with a specialist. For someone with mild persistent asthma, an observational study might be a lower-commitment way to contribute to research.
Comparison of Asthma Clinical Trial Types
| Trial Type | What It Involves | Typical Duration | Best For | Key Consideration |
|---|
| Phase I Interventional | Small group testing a new drug for safety | Weeks to months | Those willing to accept higher uncertainty | Limited data on effectiveness |
| Phase II/III Interventional | Larger groups testing efficacy and dosing | 6 months to 2 years | People with moderate to severe asthma | May involve placebo group |
| Phase IV (Post-Market) | Monitoring approved drugs long-term | 1 to 5 years | Patients already on or considering the drug | Lower risk, drug already FDA-reviewed |
| Observational | No treatment given; data collection only | Varies widely | Mild asthma patients; those wanting lower commitment | No direct treatment benefit |
| Biologic-Specific Trials | Testing monoclonal antibodies for severe asthma | 6 months to 2+ years | Severe eosinophilic or allergic asthma patients | Frequent clinic visits often required |
Who Can Join — and Who Cannot
Eligibility criteria are the gatekeepers of every clinical trial. Researchers design them carefully to protect participants and ensure the data they collect is meaningful.
Most asthma trials require that participants have a documented diagnosis for at least 12 months. Lung function tests are standard: a bronchodilator reversibility test showing that FEV1 improves by more than 12% after using a rescue inhaler is a common benchmark. Many studies also require that participants have been on a stable dose of inhaled corticosteroids for a set period — often 28 days or more — before enrollment.
Age ranges vary. Some trials focus on adolescents aged 12 to 17. Others recruit adults between 18 and 80. A few, like certain pediatric asthma studies funded through academic medical centers, enroll children as young as 2.
Exclusion criteria are equally important. People with other lung conditions — COPD, cystic fibrosis, pulmonary fibrosis, or bronchiectasis — are typically excluded. Current smokers or those with a significant smoking history may also be ruled out, depending on the study. Occupational asthma, vocal cord dysfunction, and recent respiratory infections can all disqualify someone.
The practical takeaway: if you are interested in a trial, do not assume you are ineligible without checking. Many patients discover they qualify for studies they would have dismissed. The study coordinators at each site are trained to walk you through the screening process, and it begins with a phone call or an online form.
What It Is Actually Like to Participate
Olivia, a teenager from North Carolina, joined a clinical trial after struggling with asthma that worsened every winter. Her mother, a communications project manager at the Duke Clinical Research Institute, was familiar with the research world and encouraged her to consider it. Olivia later described the experience as "pretty cool" — she earned compensation for reaching study milestones and used some of the money to attend her school's winter formal.
Her story reflects something that recruitment materials often gloss over: participating in a trial is not just about the medicine. It is about the relationship you build with the study team. Participants frequently mention that the doctors and coordinators were more attentive than their regular providers — not because the care was necessarily better, but because the structure of a trial demands close monitoring.
Visits typically involve lung function tests, blood work, and questionnaires about symptoms and quality of life. The Asthma Control Questionnaire (ACQ-5) is a common tool used to measure how well a person's asthma is being managed. Some trials require daily symptom diaries or periodic use of a peak flow meter at home.
Compensation practices vary. Most trials reimburse participants for time and travel, though the amounts depend on the study length, the number of visits, and the sponsor. Some trials pay per completed visit; others provide a lump sum at the end. The key is to ask about compensation during the informed consent process — study coordinators are required to disclose this information before you commit.
One participant, reflecting on her experience in a trial search survey, said: "I would absolutely recommend being a part of a clinical trial to anyone like me who was out of options. I would have gotten involved sooner if I had known more about studies and how they work."
How to Find Asthma Clinical Trials Near You
The most comprehensive starting point is ClinicalTrials.gov, a database maintained by the National Institutes of Health. Searching for "asthma" and filtering by location, age group, and trial phase will surface dozens of active studies. The site lists contact information for each study site, along with detailed eligibility criteria and a plain-language summary of the study's purpose.
Beyond the federal database, regional allergy and asthma clinics often run their own trials. The Midwest Allergy Sinus Asthma group, for example, regularly posts recruitment notices for inhaler studies and biologic trials. University medical centers — Duke, UCLA, the University of Chicago, and the Albert Einstein College of Medicine in New York — are hubs for asthma research. Checking their websites or calling their research departments directly can uncover studies that have not yet been widely advertised.
A few practical steps:
Start with your own specialist. Pulmonologists and allergists frequently know about trials in their region. Even if they are not directly involved in research, they can often point you toward colleagues who are.
Search using specific terms. On ClinicalTrials.gov, try "severe asthma," "eosinophilic asthma," or "pediatric asthma" rather than the broad term "asthma." Adding your city or state narrows the results. Long-tail searches like "asthma clinical trials near me" or "severe asthma research studies [state]" can surface local opportunities.
Contact more than one study site. Eligibility criteria differ slightly between trials. If you do not qualify for one, the coordinator may know of another study that fits your profile.
Ask questions before enrolling. The informed consent document is dense, but it contains the answers to most concerns: how often you will need to visit the clinic, what procedures are involved, whether you can continue your current medications, and what happens if you experience side effects. Write down your questions before the screening call.
Understand your right to withdraw. You can leave a clinical trial at any time, for any reason. This is not always emphasized in recruitment materials, but it is a fundamental protection embedded in the research ethics framework in the United States.
The Bigger Picture
Asthma clinical trials are not right for everyone. They require time, flexibility, and a tolerance for uncertainty. But for those who have cycled through inhalers and pills without lasting relief, they represent something that the standard healthcare system cannot always provide: a shot at a treatment that might actually change the trajectory of the disease. The research community needs participants — and participants need the research community to keep pushing forward. For anyone curious about what is out there, the first step is as simple as opening a browser and typing a few words into a search bar.
研究の知恵